Analyst Research
| Report Title | Price |
|---|---|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
|
Provider: Wright Reports
|
$472.00
|
|
Provider: GlobalData
|
$125.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Zhejiang CONBA Pharmaceutical Co Ltd Announces FY 2012 Dividend Payment
Zhejiang CONBA Pharmaceutical Co Ltd announced that it will pay a cash dividend of RMB 1.20 per 10 shares (pre-tax) to shareholders for fiscal year 2012.
Latest Developments for Zhejiang CONBA Pharmaceutical Co Ltd
Latest Key Developments in Pharmaceuticals
- Grifols SA’s Study Demonstrates Higher Dose Of PROLASTIN-C Increases Levels Of Alpha1-PI To Within Normal Range In Patients With AAT Deficiency-DJ
- Protalex Inc Announces Positive Interim Review of Phase 1b Trial Of PRTX-100 in Rheumatoid Arthritis By Independent Data Safety Monitoring Committee
- Pfizer Inc Announces Plan For Split-Off Of Zoetis Inc
- Salix Pharmaceuticals Ltd Announces Results For Budesonide Foam In Treatment Of Active Mild To Moderate Ulcerative Proctitis Or Ulcerative Proctosigmoiditis In Two Pivotal Phase 3 Studies
- Share this
- Link this
- Digg this
Follow Reuters